Our Exciting Journey to ACT-451840

We describe our work resulting in the selection of ACT-451840 ( 38 ) as a novel antimalarial drug with a novel mode of action. The compound was broadly characterized in vitro as well as in vivo in rat PK experiments as well as two different mouse malaria models. In the P. berghei infected mouse mode...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Christoph Boss, Sergio Wittlin
Format: article
Langue:DE
EN
FR
Publié: Swiss Chemical Society 2021
Sujets:
Accès en ligne:https://doaj.org/article/93b7c702dfa74ab3aef04287a807090c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!